Back to results
US 2019/0194154 A1Published application
Polymorphic Forms Of Vortioxetine Hydrobromide Tert-Butanolate
AssigneeAmneal Pharmaceuticals, LLC
InventorsVirendra Kumar Agarwal, Joseph Prabahar Koilpillai, Abhay Subodhbhai Maheta, Rajesh Gangarambhai Rupala, Pankaj Chaganbhai Butani, Parag Vrujlal Ajudia, Chirag Mansukhbhai Jethva
Life of this patent
Estimating the term…
Abstract
The present invention provides novel polymorphic forms of vortioxetine hydrobromide (I).
Claims20
A crystalline Form R1 of Vortioxetine hydrobromide tert-butanol solvate characterized by X-ray powder diffraction pattern having peaks at 6.7, 8.6, 15.9 and 19.1±0.2°2θ.
A crystalline Form R2 of Vortioxetine hydrobromide tert-butanol solvate characterized by X-ray powder diffraction pattern having peaks at 7.5, 10.0, 18.1 and 20.2±0.2°2θ.
Dependencies are inferred from the claim text.